Drug: LAMIVUDINE. Injury: Exposure during pregnancy Quarter: 2016Q3
Total Records: 49 Number of Pages: 3
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
127905151 | LAMIVUDINE. | Exposure during pregnancy | CIPLA | 0.00 | 0 | 20160929 | US | |
127905661 | LAMIVUDINE. | Exposure during pregnancy | CIPLA | 0.00 | 0 | 20160929 | US | |
127905671 | LAMIVUDINE. | Exposure during pregnancy | CIPLA | 0.00 | 0 | 20160929 | US | |
127983501 | LAMIVUDINE. | Exposure during pregnancy | CIPLA | 0.00 | 0 | 20160930 | US | |
127984221 | LAMIVUDINE. | Exposure during pregnancy | CIPLA | 0.00 | 0 | 20160930 | US | |
127985261 | LAMIVUDINE. | Exposure during pregnancy | CIPLA | 0.00 | 0 | 20160930 | US | |
127986081 | LAMIVUDINE. | Exposure during pregnancy | CIPLA | 0.00 | 0 | 20160930 | US | |
127987141 | LAMIVUDINE. | Exposure during pregnancy | CIPLA | 0.00 | 0 | 20160930 | US | |
127987541 | LAMIVUDINE. | Exposure during pregnancy | CIPLA | 0.00 | 0 | 20160930 | US |
Total Records: 49 Number of Pages: 3